The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.
Targeting Q1 2026 Launch, Subject to FDA Clearance Key Highlights: Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale ...
Modern technology remains a privilege, not a right, as families of people with diabetes struggle to afford rising ...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
Targeting Q1 2026 Launch, Subject to FDA ClearanceKey Highlights:Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale ...
Dr Anne Peters discusses updates in the ADA 2026 Standards of Care in Diabetes, focusing on the use of technology.
A new study published in the journal of Diabetes Technology & Therapeutics showed that during very-low carbohydrate states in ...
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
A Washington mother is facing a manslaughter charge after prosecutors say she drove hundreds of miles with her diabetic ...
Q: What is the MiniMed™ 780G system? A: It's Medtronic's most advanced automated insulin delivery system that automatically adjusts insulin every five minutes based on real-time glucose readings, ...
ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, announced today that Reman McDonagh, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results